Oncogenic KRAS signalling in pancreatic cancer
Top Cited Papers
Open Access
- 22 April 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 111 (5), 817-822
- https://doi.org/10.1038/bjc.2014.215
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFRNature, 2012
- Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissuesThe Journal of Pathology, 2011
- PTEN Is a Major Tumor Suppressor in Pancreatic Ductal Adenocarcinoma and Regulates an NF-κB–Cytokine NetworkCancer Discovery, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerThe New England Journal of Medicine, 2011
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyNature Medicine, 2011
- Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral SignalingCancer Research, 2010
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell SurvivalCancer Cell, 2009
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)Science, 1999
- On the Origin of Cancer CellsScience, 1956